G1 Therapeutics, Inc. (GTHX) Financials

GTHX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 121.5 million 86.2 million
2023-09-30 133.1 million 90.1 million
2023-06-30 147.9 million 90.3 million
2023-03-31 162.0 million 117.0 million

GTHX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -12.8 million 3.2 million
2023-09-30 -10.6 million 3.7 million
2023-06-30 14.1 million 3.8 million
2023-03-31 -29.1 million 3.8 million

GTHX Net Income

No data available :(

GTHX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 82.2 million - 4.3 million
2023-09-30 94.4 million - 4.7 million
2023-06-30 104.2 million 50.9 million 5.0 million
2023-03-31 116.3 million 77.5 million 5.3 million

GTHX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.8 million
2023-09-30 51.8 million
2023-06-30 61.0 million
2023-03-31 51.6 million

GTHX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 7.4 million 15.2 million -
2023-09-30 - 8.8 million 16.8 million -
2023-06-30 - 12.0 million 18.8 million -
2023-03-31 - 15.5 million 23.2 million -

GTHX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 14.9 million 1.3 million
2023-09-30 12.3 million 3.1 million
2023-06-30 42.4 million 1.4 million
2023-03-31 12.9 million 1.5 million

GTHX

Price: $3.99

52 week price:
1.08
5.00

Earnings Per Share: -0.93 USD

P/E Ratio: -1.68

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 586179

Ebitda: -15.9 million

Market Capitalization: 225.0 million

Links: